StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Earnings

Neogen's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Jan 7, 2027
Q2 FY2027 · estimated, before the open
Revenue, Q1 FY2027
$222.80M
+6.5% on a year earlier
Adjusted Earnings Per Share, Q1 FY2027
$0.08
$0.04 a year earlier
Latest guidance
Raised
Oct 6, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Neogen's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q2 FY2027ended Nov 30, 2026Jan 7, 2027Expected–––––
Q1 FY2027ended Aug 31, 2026Oct 6, 2026after the close$222.80M+6.5%-$0.05$0.08Release
Q4 FY2026ended May 31, 2026Jul 30, 2026before the open$225.30M-0.1%-$0.05$0.09Release
Q3 FY2026ended Feb 28, 2026Apr 9, 2026before the open$211.20M-4.4%-$0.08$0.09Release
Q2 FY2026ended Nov 30, 2025Jan 8, 2026before the open$224.70M-2.9%-$0.07$0.10Release
Q1 FY2026ended Aug 31, 2025Oct 9, 2025before the open$209.20M-3.6%$0.17$0.04Release
Q4 FY2025ended May 31, 2025Jul 29, 2025before the open$225.50M-4.8%-$2.82$0.05Release
Q3 FY2025ended Feb 28, 2025Apr 9, 2025before the open$221.00M-3.4%-$0.05$0.10Release
Q2 FY2025ended Nov 30, 2024Jan 10, 2025before the open$231.30M+0.7%-$2.10$0.11Release
Q1 FY2025ended Aug 31, 2024Oct 10, 2024before the open$217.00M-5.2%-$0.06$0.07Release
Q4 FY2024ended May 31, 2024Jul 30, 2024before the open$236.80M-2.1%-$0.02$0.10Release
Q3 FY2024ended Feb 29, 2024Apr 9, 2024before the open$228.80M+4.8%-$0.01$0.12Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Neogen's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
total revenueFY2027$885.00M – $890.00M$880.00M – $885.00MRaisedOct 6, 2026
Adjusted EBITDAnon-GAAPFY2027$181.00M – $183.00M$180.00M – $182.00MRaisedOct 6, 2026

Guidance vs results

The last range Neogen gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q1 FY2027Revenue$207.00M – $209.00M$222.80MAbove range
FY2026Revenue$857.00M – $860.00M$870.40MΣ4QAbove range
FY2025Revenue$895.00M$894.80MΣ4QWithin range

Guidance history

Every forecast Neogen put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 6, 2026Adjusted EBITDAFY2027$181.00M – $183.00MRaised
Oct 6, 2026total revenueFY2027$885.00M – $890.00MRaised
Jul 30, 2026adjusted EBITDAFY2027$180.00M – $182.00MNew
Jul 30, 2026Adjusted EBITDAQ1 FY2027$37.00MNew
Jul 30, 2026total revenueFY2027$880.00M – $885.00MNew
Jul 30, 2026total revenueQ1 FY2027$207.00M – $209.00MNew
Apr 9, 2026adjusted EBITDAFY2026$175.00MReaffirmed
Apr 9, 2026revenueFY2026$857.00M – $860.00MRaised
Jan 8, 2026Capital expendituresFY2026$50.00MReaffirmed
Jan 8, 2026Adjusted EBITDAFY2026$175.00MRaised
Jan 8, 2026RevenueFY2026$845.00M – $855.00MRaised
Oct 9, 2025Capital expendituresFY2026$50.00MReaffirmed
Oct 9, 2025Adjusted EBITDAFY2026$165.00M – $175.00MReaffirmed
Oct 9, 2025RevenueFY2026$820.00M – $840.00MReaffirmed
Jul 29, 2025Capital expendituresFY2026$50.00MNew
Jul 29, 2025Adjusted EBITDAFY2026$165.00M – $175.00MNew
Jul 29, 2025RevenueFY2026$820.00M – $840.00MNew
Apr 9, 2025capital expendituresFY2025$100.00MNew
Apr 9, 2025Adjusted EBITDAFY2025$195.00MNew
Apr 9, 2025RevenueFY2025$895.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Neogen filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. News
  6. Results
  7. News
  8. News
  9. News
  10. Results
  11. Update
  12. Update
  13. News
  14. Update
  15. Results

See a number that looks wrong?